Multiplexed in vivo epigenome engineering for therapeutic targeting of chronic pain
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210401
- Recipient
-
University Of California, San Diego UEI M1J2S44RMJD4 Part of State Of California Controllers Office
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,528,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- La Jolla, CA 92093, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded a $2,528,000 Project Grant to the University of California, San Diego under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research titled "MULTIPLEXED IN VIVO EPIGENOME ENGINEERING FOR THERAPEUTIC TARGETING OF CHRONIC PAIN." The four-year project beginning June 1, 2022 will investigate medical solutions for chronic pain through innovative epigenome engineering research with the goal of transforming health care for service members and the public. As the prime awardee, UC San Diego will conduct the proposed research and is a subsidiary of the State of California Controllers Office for grant administration purposes. The award aims to advance the Military Medical Research and Development program's mission of supporting basic, applied, and advanced biomedical research to improve warfighter health and wellness.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $2,528,000 |
Quick answers
Who received award W81XWH2210401?
W81XWH2210401 was awarded to University Of California, San Diego by Defense Health Agency (Department of Defense) on June 1, 2022.
How much is award W81XWH2210401 worth?
$2,528,000 has been obligated on W81XWH2210401.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award